Thursday, November 19, 2026
News

New study sheds light on growth of human triple negative breast cancers

SocialTwist Tell-a-Friend    Print this Page   COMMENT

Boston | November 29, 2022 2:00:33 AM IST
Basal-like breast cancers, also known as triple-negative cancers, are a particularly aggressive subtype of breast cancer with limited treatment options. Although the origin of luminal (cells that line the surface of the breast duct) and basal subtypes of breast cancer is unknown, studies suggest that basal-like cancers can arise from luminal epithelial cells.

In a new study, researchers from Boston University Chobanian & Avedisian School of Medicine demonstrated that proper control of a cellular pathway known as the Hippo pathway prevents the development of triple-negative breast cancer.

These findings appear online in the journal Nature Communications.

"We found that when this pathway is dysregulated or impaired, luminal epithelial cells in the mammary gland rapidly transition to a basal-like state and develop into triple negative carcinomas," explained corresponding author Bob Varelas, PhD, associate professor of biochemistry.

In an experimental model, the researchers conditionally deleted the Lats1 and Lats2 genes, two components of the Hippo pathway, in the luminal epithelium of the mammary glands. When these genes were deleted, the models rapidly develop basal-like mammary carcinomas resembling human basal-like breast cancers. They found that the development of these carcinomas depended on the activity of the Hippo pathway effector proteins YAP and TAZ, and that deletion of these two proteins reversed carcinoma development in their model.

According to the researchers, the gene-expression signature identified from Lats1/2-deleted tumors could be used to identify aggressive features associated with triple negative breast cancers. Since basal-like breast cancers are notoriously difficult to treat, Varelas hopes these findings may be leveraged to help guide new directions for better treatment and improved patient outcomes. "A better understanding of the cellular mechanisms leading to the development of these cancers is essential to identifying new therapeutic options," he said. (ANI)

 
  LATEST COMMENTS (0)
POST YOUR COMMENT
Comments Not Available
 
POST YOUR COMMENT
 
 
TRENDING TOPICS
 
 
CITY NEWS
MORE CITIES
 
 
 
MORE HEALTH NEWS
Delhi's iconic landmarks light up in tea...
Jumping genes may help brain cells produ...
Vitamin B12 may hold key to treating a r...
This surprising brain difference may exp...
Scientists discover crows can make decis...
VedaNova Cares First Mumbai Clinic Help...
More...
 
INDIA WORLD ASIA
Himachal CM Sukhu expresses grief over d...
Severe Cyclone Akvan likely to cross And...
'Chunav nahi hoga, Inquilab hoga': SP le...
Congress approves 42-member Pradesh Elec...
G Kishan Reddy to bear SSC examination f...
Udhayanidhi Stalin slams Tamil Nadu DGP,...
More...    
 
 Top Stories
"Double standard unmistakable": Ira... 
Neither party in Israel offering pa... 
Tibetan Youth Congress launches glo... 
1st Test: Bumrah strikes twice as I... 
"Great to get it off his chest": Wa... 
Indian Navy's INS Sahyadri, Canadia... 
"Chunav nahi hoga, Inquilab hoga": ... 
"No one can replace Jensen": Elon M...